These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22530798)

  • 21. Designer Drugs 2.0.
    Huestis MA; Tyndale RF
    Clin Pharmacol Ther; 2017 Feb; 101(2):152-157. PubMed ID: 28084644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
    Tung CK; Chiang TP; Lam M
    East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Finding order in chemical chaos - Continuing characterization of synthetic cannabinoid receptor agonists.
    Marusich JA; Wiley JL; Lefever TW; Patel PR; Thomas BF
    Neuropharmacology; 2018 May; 134(Pt A):73-81. PubMed ID: 29113898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spice and all things nasty: the challenge of synthetic cannabinoids.
    Kalk NJ; Boyd A; Strang J; Finch E
    BMJ; 2016 Oct; 355():i5639. PubMed ID: 27777237
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.
    Fattore L
    Biol Psychiatry; 2016 Apr; 79(7):539-48. PubMed ID: 26970364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.
    Davidson C; Opacka-Juffry J; Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E; Molina-Holgado F
    Adv Pharmacol; 2017; 80():135-168. PubMed ID: 28826533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacological properties and dependence liabilities of synthetic cannabinoids].
    Funada M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):167-74. PubMed ID: 20681249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Spice" girls: synthetic cannabinoid intoxication.
    Schneir AB; Cullen J; Ly BT
    J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic cannabinoids: the hidden side of Spice drugs.
    Pintori N; Loi B; Mereu M
    Behav Pharmacol; 2017 Sep; 28(6):409-419. PubMed ID: 28692429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baths salts, spice, and related designer drugs: the science behind the headlines.
    Baumann MH; Solis E; Watterson LR; Marusich JA; Fantegrossi WE; Wiley JL
    J Neurosci; 2014 Nov; 34(46):15150-8. PubMed ID: 25392483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis: discrimination of "internal bliss"?
    Wiley JL
    Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-administration of cannabinoids by experimental animals and human marijuana smokers.
    Justinova Z; Goldberg SR; Heishman SJ; Tanda G
    Pharmacol Biochem Behav; 2005 Jun; 81(2):285-99. PubMed ID: 15932767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient.
    Peglow S; Buchner J; Briscoe G
    Am J Addict; 2012; 21(3):287-8. PubMed ID: 22494236
    [No Abstract]   [Full Text] [Related]  

  • 37. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis, cannabinoids, and health.
    Lafaye G; Karila L; Blecha L; Benyamina A
    Dialogues Clin Neurosci; 2017 Sep; 19(3):309-316. PubMed ID: 29302228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction.
    Chang X; Bian Y; He Q; Yao J; Zhu J; Wu J; Wang K; Duan T
    Cell Physiol Biochem; 2017; 42(2):537-550. PubMed ID: 28578322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.
    Irie T; Kikura-Hanajiri R; Usami M; Uchiyama N; Goda Y; Sekino Y
    Neuropharmacology; 2015 Aug; 95():479-91. PubMed ID: 25747605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.